CLAY B SIEGALL Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CLAY B SIEGALL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CLAY B SIEGALL. CLAY B SIEGALL is President & CEO in SEATTLE GENETICS INC /WA ($SGEN) and President and CEO in SEATTLE GENETICS INC /WA ($SGEN) and See Remarks in SEATTLE GENETICS INC /WA ($SGEN) and Director in ALDER BIOPHARMACEUTICALS INC ($ALDR) and in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Mirna Therapeutics, Inc. ($MIRN).
Latest Insider Trading Transactions of CLAY B SIEGALL
Sentiment: All, ALDR, SGEN, SYBX, RARE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 02 2005 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 5.90 | 10,000 | 59,000 | 1,225,000 | 1.2 M to 1.2 M (-0.81 %) |
| Aug 02 2005 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 6.02 | 15,000 | 90,260 | 1,235,000 | 1.3 M to 1.2 M (-1.20 %) |
| Aug 02 2005 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 6.00 | 15,000 | 90,015 | 1,250,000 | 1.3 M to 1.3 M (-1.19 %) |
| Aug 02 2005 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 6.00 | 5,000 | 30,000 | 1,265,000 | 1.3 M to 1.3 M (-0.39 %) |
| Aug 02 2005 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 5.99 | 11,500 | 68,908 | 1,270,000 | 1.3 M to 1.3 M (-0.90 %) |
| Aug 02 2005 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 5.95 | 5,000 | 29,750 | 1,281,500 | 1.3 M to 1.3 M (-0.39 %) |
| Jul 15 2005 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Gift | G | 0.00 | 5,000 | 0 | 1,286,500 | 1.3 M to 1.3 M (-0.39 %) |
| Feb 02 2005 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | A | 5.92 | 56,004 | 331,544 | 56,004 | |
| Feb 02 2005 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | A | 5.92 | 18,996 | 112,456 | 18,996 | |
| Feb 19 2004 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | A | 10.33 | 37,858 | 391,073 | 37,858 | |
| Feb 19 2004 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | A | 10.33 | 12,142 | 125,427 | 12,142 | |
| Dec 01 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 6.50 | 2,000 | 13,000 | 1,341,500 | 1.3 M to 1.3 M (-0.15 %) |
| Dec 01 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 6.40 | 2,500 | 16,000 | 1,343,500 | 1.3 M to 1.3 M (-0.19 %) |
| Dec 02 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 6.54 | 5,000 | 32,700 | 1,291,500 | 1.3 M to 1.3 M (-0.39 %) |
| Dec 02 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 6.50 | 7,500 | 48,750 | 1,296,500 | 1.3 M to 1.3 M (-0.58 %) |
| Dec 02 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 6.49 | 10,000 | 64,900 | 1,304,000 | 1.3 M to 1.3 M (-0.76 %) |
| Dec 02 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 6.49 | 5,000 | 32,435 | 1,314,000 | 1.3 M to 1.3 M (-0.38 %) |
| Dec 02 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 6.48 | 7,500 | 48,563 | 1,319,000 | 1.3 M to 1.3 M (-0.57 %) |
| Dec 02 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 6.45 | 5,000 | 32,250 | 1,326,500 | 1.3 M to 1.3 M (-0.38 %) |
| Dec 02 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 6.40 | 10,000 | 64,000 | 1,331,500 | 1.3 M to 1.3 M (-0.75 %) |
| Nov 24 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 6.60 | 3,000 | 19,800 | 1,346,000 | 1.3 M to 1.3 M (-0.22 %) |
| Nov 24 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 6.50 | 5,500 | 35,750 | 1,349,000 | 1.4 M to 1.3 M (-0.41 %) |
| Nov 24 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 6.60 | 3,500 | 23,100 | 1,354,500 | 1.4 M to 1.4 M (-0.26 %) |
| Nov 24 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 6.55 | 2,500 | 16,375 | 1,358,000 | 1.4 M to 1.4 M (-0.18 %) |
| Nov 24 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 6.52 | 20,000 | 130,360 | 1,360,500 | 1.4 M to 1.4 M (-1.45 %) |
| Nov 24 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 6.50 | 22,000 | 143,000 | 1,380,500 | 1.4 M to 1.4 M (-1.57 %) |
| Sep 16 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 5.90 | 7,500 | 44,250 | 1,402,500 | 1.4 M to 1.4 M (-0.53 %) |
| Sep 16 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 5.90 | 2,500 | 14,750 | 1,410,000 | 1.4 M to 1.4 M (-0.18 %) |
| Sep 11 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 6.00 | 9,000 | 54,000 | 1,412,500 | 1.4 M to 1.4 M (-0.63 %) |
| Sep 11 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 5.95 | 10,000 | 59,500 | 1,421,500 | 1.4 M to 1.4 M (-0.70 %) |
| Sep 11 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 5.90 | 9,000 | 53,100 | 1,431,500 | 1.4 M to 1.4 M (-0.62 %) |
| Sep 11 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 6.14 | 4,500 | 27,635 | 1,440,500 | 1.4 M to 1.4 M (-0.31 %) |
| Sep 11 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 6.21 | 15,000 | 93,132 | 1,445,000 | 1.5 M to 1.4 M (-1.03 %) |
| Sep 08 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 6.20 | 3,500 | 21,700 | 1,460,000 | 1.5 M to 1.5 M (-0.24 %) |
| Sep 08 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 6.17 | 1,500 | 9,255 | 1,463,500 | 1.5 M to 1.5 M (-0.10 %) |
| Sep 08 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 6.14 | 6,000 | 36,840 | 1,465,000 | 1.5 M to 1.5 M (-0.41 %) |
| Sep 08 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 6.12 | 10,000 | 61,200 | 1,471,000 | 1.5 M to 1.5 M (-0.68 %) |
| Sep 08 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 6.24 | 5,500 | 34,320 | 1,481,000 | 1.5 M to 1.5 M (-0.37 %) |
| Sep 08 2003 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 6.25 | 5,000 | 31,250 | 1,486,500 | 1.5 M to 1.5 M (-0.34 %) |